Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Weiser

Showing results (121-130 of 176) with videos related to

Pageof 18
Sort By:
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|December 20, 2013
Mental pain, communication difficulties, and medically serious suicide attempts: a case-control studyYossi Levi-Belz, Yari Gvion, Netta Horesh, et al.
Bipolar Disorders|April 10, 2014
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorderMark Weiser, Shimon Burshtein, Ari A Gershon, et al.
Schizophrenia Bulletin|January 22, 2021
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled TrialsMark Weiser, Daisy Zamora, Linda Levi, et al.
The American Journal of Psychiatry|July 29, 2017
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
Schizophrenia Bulletin|February 25, 2022
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2007
Social and cognitive functioning, urbanicity and risk for schizophreniaMark Weiser, Jim van Os, Abraham Reichenberg, et al.
Translational Psychiatry|March 18, 2026
The role of the dorsal attention network in attention bias modification for social anxiety disorderYael Coldham, Noga Yair, Omer Azriel, et al.
Psychological Medicine|March 5, 2019
Understanding the association between advanced paternal age and schizophrenia and bipolar disorderMark Weiser, Daphna Fenchel, Or Frenkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
Discontinuity in the genetic and environmental causes of the intellectual disability spectrumAbraham Reichenberg, Martin Cederlöf, Andrew McMillan, et al.
Frontiers in Psychiatry|August 14, 2023
Technologically assisted intensive home treatment: feasibility studyAsaf Caspi, Dana Tzur Bitan, Ofir Halaly, et al.
Pageof 18

Showing results (121-130 of 176) with videos related to

Sort By:
Pageof 18
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|December 20, 2013
Mental pain, communication difficulties, and medically serious suicide attempts: a case-control studyYossi Levi-Belz, Yari Gvion, Netta Horesh, et al.
Bipolar Disorders|April 10, 2014
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorderMark Weiser, Shimon Burshtein, Ari A Gershon, et al.
Schizophrenia Bulletin|January 22, 2021
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled TrialsMark Weiser, Daisy Zamora, Linda Levi, et al.
The American Journal of Psychiatry|July 29, 2017
Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
Schizophrenia Bulletin|February 25, 2022
Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of SchizophreniaMichael Davidson, Jay Saoud, Corinne Staner, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2007
Social and cognitive functioning, urbanicity and risk for schizophreniaMark Weiser, Jim van Os, Abraham Reichenberg, et al.
Translational Psychiatry|March 18, 2026
The role of the dorsal attention network in attention bias modification for social anxiety disorderYael Coldham, Noga Yair, Omer Azriel, et al.
Psychological Medicine|March 5, 2019
Understanding the association between advanced paternal age and schizophrenia and bipolar disorderMark Weiser, Daphna Fenchel, Or Frenkel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
Discontinuity in the genetic and environmental causes of the intellectual disability spectrumAbraham Reichenberg, Martin Cederlöf, Andrew McMillan, et al.
Frontiers in Psychiatry|August 14, 2023
Technologically assisted intensive home treatment: feasibility studyAsaf Caspi, Dana Tzur Bitan, Ofir Halaly, et al.
Pageof 18